Fifth GAVI Board Meeting, 21-22 June 2001, London, England
Developing Country Vaccine Manufacturers Network
welcomed the development of a new network of developing country vaccine
Powerpoint file approx. 139kb), and urged close collaboration between
this network and the IFPMA.
industry should be viewed as an international industry, and not
stratified between manufacturers from developing and industrialized
countries. In this context, the Board confirmed the need for an adequate
number of active producers of vaccines in developing and industrialized
countries, and maintaining an environment of fair competition while at
the same time identifying gaps in research and development.